📰 Efficacy Supplement News
Efficacy Supplement News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Efficacy Supplement. Real-time updates on events, politics, business and more.
May 5, 2024
Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.
February 16, 2024
– Priority review granted, with a review goal date of June 21, 2024 ...
February 16, 2024
Sarepta's Elevidys efficacy supplement accepted for Duchenne muscular dystrophy treatment expansion, potential $1 billion yearly opportunity. FDA review goal: June 21, 2024.
February 16, 2024
(RTTNews) - Sarepta Therapeutics, Inc. (SRPT) announced on Friday that it has been granted Priority Review status by the FDA for its Efficacy Supp...